Institutional investors hold a majority ownership of MEIP through the 58.91% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended June 2014, these large investors purchased a net $1.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LMR PARTNERS LLP Sold 26.1 Thousand shares of MEI Pharma Inc